시장보고서
상품코드
1684425

세계의 호흡기 질환 검사 시장 : 제품별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 점유율 및 예측(2025-2032년)

Respiratory Disease Testing Market, By Product, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 322 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

호흡기 질환 검사 시장 규모는 2024년 65억 9,043만 달러로 평가되었고, 2025-2032년 연평균 2.99% 성장할 것으로 예상됩니다.

호흡기 질환 검사 시장 역학

감염성 호흡기 질환의 확산과 디지털 통합 증가로 시장 수요 증가 전망

호흡기 질환 검사 시장은 호흡기 질환의 유병률 증가와 기술 발전 등 다양한 요인이 겹치면서 큰 폭의 성장이 예상됩니다. 천식, 만성폐쇄성폐질환(COPD), 간질성폐질환 등 만성 호흡기 질환은 증가 추세에 있습니다. 세계보건기구(WHO)에 따르면 COPD는 전 세계 주요 사망 원인 중 하나이며, 천식은 전 세계 수억 명이 앓고 있습니다. 또한, RT-PCR과 같은 신속 검사법이 일반화되면서 진단 실험실은 그 역량을 확장했습니다.

또한, 분자진단학, 중합효소연쇄반응(PCR) 검사, 차세대염기서열분석(NGS) 등의 새로운 기술은 호흡기 질환의 검출 민감도와 특이성을 향상시켰습니다. 휴대가 가능하고 신속한 진단 도구의 등장으로 호흡기 질환 검사가 더욱 친숙해졌습니다. 이러한 장비는 원격지나 응급상황에서 특히 유용합니다. 인공지능(AI)과 머신러닝(ML)이 진단 프로세스에 통합되어 속도와 정확도가 향상되고 있으며, AI 기반 도구는 흉부 엑스레이 및 CT 스캔과 같은 영상 검사의 해석을 돕고 있습니다. 또한, 고급 진단 도구의 높은 비용과 의료 접근성 격차는 원격 의료 및 저비용 검사 솔루션과 같은 기술 혁신을 촉진하여 성장을 더욱 촉진하고 있습니다.

호흡기 질환 검사 시장 : 주요 고찰

당사의 리서치 애널리스트들의 분석에 따르면, 세계 시장은 예측 기간(2025-2032년) 동안 약 2.99%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.

제품별로는 엑스레이 영상 채택 증가로 인해 영상 검사 부문이 2024년 가장 높은 시장 점유율을 차지했습니다.

용도별로는 결핵의 높은 유병률과 진단의 필요성 때문에 결핵 분야가 2024년 주요 용도 분야가 되었습니다.

최종 사용자별로는 엑스레이 장비와 같은 첨단 의료기기의 도입이 증가함에 따라 2024년에는 병원 분야가 최종 사용자 분야에서 선두를 차지할 것으로 예상됩니다.

지역별로는 천식 및 기타 호흡기 질환의 높은 유병률로 인해 북미가 2024년 주요 수익원이 되었습니다.

호흡기 질환 검사 시장 : 세분화 분석

호흡기 질환 검사 세계 시장은 제품, 용도, 최종 사용자 및 지역에 따라 세분화됩니다.

제품별로는 영상 검사, 혈액가스 검사, 호흡기 측정 장치, 기타 등 4가지로 분류됩니다. 영상 검사 분야가 시장을 주도하고 있으며, X선 장비 및 3D 영상 플랫폼과 같은 첨단 영상 장비의 높은 도입이 이 부문의 성장을 견인하고 있습니다.

시장은 용도별로 폐암, 결핵, 천식, 만성폐쇄성폐질환(COPD), 기타 등 5가지로 분류됩니다. 가장 큰 비중을 차지하는 것은 결핵입니다. 폐암 부문은 예방 진단 치료의 필요성으로 인해 예측 기간 동안 가장 빠른 속도로 성장할 것으로 예상됩니다.

시장은 최종 사용자별로 병원, 임상 실험실, 기타 세 가지로 분류됩니다. 최종 사용자별로는 병원 부문이 가장 큰 점유율을 차지하고 있습니다. 호흡기 질환의 유병률 증가, 첨단 장비를 통한 환자 진단에 대한 높은 요구가 이 부문 수요에 기여하고 있습니다.

호흡기 질환 검사 시장 : 지역별 분석

호흡기 질환 검사 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 걸쳐 분포되어 있습니다. 북미가 세계 호흡기 질환 검사 시장에서 큰 점유율을 차지하고 있는 것은 선진적인 헬스케어 인프라, 첨단 진단법의 높은 채택률, 강력한 R&D 투자에 기인합니다. 미국 폐협회에 따르면 2023년에는 약 1,600만 명의 미국인이 COPD 진단을 받을 것으로 예상됩니다. 아시아태평양은 많은 환자 인구, 의료 인프라 개선, 투자 증가로 인해 호흡기 질환 검사 시장에서 가장 높은 성장세를 보일 것으로 예상됩니다. 중국이나 인도와 같은 국가들은 공해와 흡연 등으로 인해 결핵(TB), COPD, 기타 호흡기 감염증의 발병률이 높습니다.

호흡기 질환 검사 시장 : 경쟁 구도

호흡기 질환 검사 시장은 경쟁이 치열하며, 다양한 진단 솔루션을 제공하는 세계 기업, 지역 기업, 스타트업이 존재합니다. 경쟁은 선진적이고 정확하고 빠른 검사법에 대한 니즈에 의해 촉진되고 있습니다. 신흥국에서는 스타트업과 중소기업이 휴대 가능하고 비용 효율적인 솔루션을 도입하여 기술 혁신에 기여하고 있습니다. 시장 관계자들은 결핵 및 폐렴과 같은 호흡기 감염에 대한 미생물학 및 분자생물학적 진단법에도 집중하고 있습니다. 각 업체들은 의료진과 환자들의 진화하는 요구에 부응하기 위해 혁신적인 진단 솔루션을 도입하기 위한 연구개발에 적극 나서고 있습니다.

목차

제1장 호흡기 질환 검사 시장 개요

  • 조사 범위
  • 시장 추정 기간

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 호흡기 질환 검사 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 향후 동향

제4장 호흡기 질환 검사 시장 : 산업 분석

  • PEST 분석
  • Porter의 Five Forces 분석
  • 시장 성장 전망 : 맵핑
  • 규제 체제 분석

제5장 호흡기 질환 검사 시장 : 높아지는 지정학적 긴장의 영향

  • COVID-19 팬데믹의 영향
  • 러시아-우크라이나 전쟁의 영향
  • 중동 분쟁의 영향

제6장 호흡기 질환 검사 시장 구도

  • 호흡기 질환 검사 시장 점유율 분석(2024년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신규 기업 분석

제7장 호흡기 질환 검사 시장 : 제품별

  • 개요
    • 부문별 점유율 분석 : 제품별
    • 영상 검사
    • 혈액가스 검사
    • 호흡 측정 장비
    • 기타

제8장 호흡기 질환 검사 시장 : 용도별

  • 개요
    • 부문별 점유율 분석 : 용도별
    • 폐암
    • 결핵
    • 천식
    • 만성 폐쇄성 폐질환(COPD)
    • 기타

제9장 호흡기 질환 검사 시장 : 최종사용자별

  • 개요
    • 부문별 점유율 분석 : 최종사용자별
    • 병원
    • 임상 실험실
    • 기타

제10장 호흡기 질환 검사 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 영국
    • 프랑스
    • 이탈리아
    • 스페인
    • 네덜란드
    • 스웨덴
    • 러시아
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 인도네시아
    • 태국
    • 필리핀
    • 기타
  • 라틴아메리카(LATAM)
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카(MEA)
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 호흡기 질환 검사 업계

  • 경쟁 대시보드
    • 경쟁 벤치마킹
    • 경쟁 포지셔닝
  • 기업 개요
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • F. Hoffmann-La Roche AG
    • Siemens Healthineers
    • Becton, Dickinson and Company(BD)
    • bioMerieux SA
    • Quest Diagnostics Incorporated
    • Danaher Corporation
    • PerkinElmer Inc.
    • MGC Diagnostics Corporation
    • Oxford Nanopore
    • Agilent Technologies, Inc.
    • Vyaire Medical, Inc.
    • Philips Healthcare
    • GE HealthCare Technologies In
    • Others

제12장 AnalystView의 전방위적 분석

LSH 25.04.15

REPORT HIGHLIGHT

Respiratory Disease Testing Market size was valued at USD 6,590.43 Million in 2024, expanding at a CAGR of 2.99% from 2025 to 2032.

Respiratory disease testing is used in diagnostic procedures to detect, evaluate, and monitor diseases affecting the respiratory system, which includes the lungs, airways, and other structures involved in breathing. These tests help identify conditions such as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, tuberculosis, lung cancer, and infections like COVID-19 virus.

Respiratory Disease Testing Market- Market Dynamics

Growing prevalence of infectious respiratory diseases and rising digital integration are expected to propel market demand

The respiratory disease testing market has is expected to witness substantial growth due to a combination of factors, including the rising prevalence of respiratory illnesses, and technological advancements. Chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung diseases are on the rise. According to the World Health Organization (WHO), COPD is among the leading causes of death worldwide, and asthma affects hundreds of millions worldwide. Further, rapid testing methods like RT-PCR became household terms, and diagnostic labs expanded their capacity.

Furthermore, New techniques, such as molecular diagnostics, polymerase chain reaction (PCR) tests, and next-generation sequencing (NGS), have improved the sensitivity and specificity of respiratory disease detection. The availability of portable and rapid diagnostic tools has made respiratory disease testing more accessible. These devices are particularly beneficial in remote areas and emergency scenarios. Artificial intelligence (AI) and machine learning (ML) are being integrated into diagnostic processes to enhance speed and accuracy. AI-powered tools are aiding in the interpretation of imaging tests like chest X-rays and CT scans. Moreover, high costs of advanced diagnostic tools and disparities in healthcare access, these issues have prompted innovations like telemedicine and low-cost testing solutions, further driving growth.

Respiratory Disease Testing Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 2.99% over the forecast period (2025-2032)

Based on Product segmentation, the imaging tests segment was predicted to show maximum market share in the year 2024, due to increased adoption of X-ray imaging.

Based on Application segmentation, the tuberculosis segment was the leading Application segment in 2024, due to high prevalence of tuberculosis and need for diagnosis.

Based on End User segmentation, the hospitals segment was the leading End User segment in 2024, due to increasing adoption of advanced medical devices like X-ray machines.

On the basis of region, North America was the leading revenue generator in 2024, owing to high prevalence of asthma, and other respiratory diseases.

Respiratory Disease Testing Market- Segmentation Analysis:

The Global Respiratory Disease Testing Market is segmented on the basis of Product, Application, End User, and Region.

The market is divided into four categories based on Product: imaging tests, blood gas test, respiratory measurement devices, and others. The imaging tests segment dominates the market. High adoption of advanced imaging devices like X-ray machines and 3D imaging platforms are fueling segment growth.

The market is divided into five categories based on the Application: lung cancer, tuberculosis, asthma, chronic obstructive pulmonary disease (COPD), and others. The tuberculosis segment is expected to hold the largest share. The lung cancer segment is estimated to grow at the fastest rate during the forecast period, due to the need for preventive diagnosis care.

The market is divided into three categories based on End User: hospitals, clinical laboratories, and others. The hospitals segment holds the largest share in the End User segment. The growing prevalence of respiratory diseases, and high need for patient diagnosis with advanced devices is contributing to segment demand.

Respiratory Disease Testing Market- Geographical Insights

Across the world, the Respiratory Disease Testing market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds a significant share of the global respiratory disease testing market due to its advanced healthcare infrastructure, high adoption of advanced diagnostics, and strong R&D investments. According to the American Lung Association, approximately 16 million Americans are diagnosed with COPD in 2023. The Asia-Pacific region is expected to witness the highest growth in the respiratory disease testing market due to a large patient population, improving healthcare infrastructure, and increased investments. Countries like China and India have high rates of tuberculosis (TB), COPD, and other respiratory infections due to pollution, smoking, etc.

Respiratory Disease Testing Market- Competitive Landscape:

The respiratory disease testing market is highly competitive, with the presence of global, regional, and emerging players offering a range of diagnostic solutions. Competition is fueled by the need for advanced, accurate, and rapid testing methods. In emerging economies, startups and smaller firms are contributing to innovation by introducing portable and cost-effective solutions. Market players also focus on microbiology and molecular diagnostics for respiratory infections like tuberculosis and pneumonia. Companies are actively engaged in research and development to introduce innovative diagnostic solutions to meet the evolving needs of healthcare providers and patients.

Recent Developments:

In October 2024, Quest Diagnostics announced the launch of a test for the H5N1 bird flu, to enhance the company's portfolio.

In October 2024, Oxford Nanopore partnered with NHS England to expedite the screening of new pathogens.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RESPIRATORY DISEASE TESTING MARKET KEY PLAYERS

  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Siemens Healthineers
  • Becton, Dickinson and Company (BD)
  • bioMerieux SA
  • Quest Diagnostics Incorporated
  • Danaher Corporation
  • PerkinElmer Inc.
  • MGC Diagnostics Corporation
  • Oxford Nanopore
  • Agilent Technologies, Inc.
  • Vyaire Medical, Inc.
  • Philips Healthcare
  • GE HealthCare Technologies Inc.
  • Others

GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • Imaging tests
  • Blood gas test
  • Respiratory measurement devices
  • Others

GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Lung cancer
  • Tuberculosis
  • Asthma
  • Chronic obstructive pulmonary disease (COPD)
  • Others

GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinical Laboratories
  • Others

GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Respiratory Disease Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Respiratory Disease Testing Market Snippet by Product
    • 2.1.2. Respiratory Disease Testing Market Snippet by Application
    • 2.1.3. Respiratory Disease Testing Market Snippet by End User
    • 2.1.4. Respiratory Disease Testing Market Snippet by Country
    • 2.1.5. Respiratory Disease Testing Market Snippet by Region
  • 2.2. Competitive Insights

3. Respiratory Disease Testing Key Market Trends

  • 3.1. Respiratory Disease Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Respiratory Disease Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Respiratory Disease Testing Market Opportunities
  • 3.4. Respiratory Disease Testing Market Future Trends

4. Respiratory Disease Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Respiratory Disease Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Respiratory Disease Testing Market Landscape

  • 6.1. Respiratory Disease Testing Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Respiratory Disease Testing Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Imaging tests
    • 7.1.3. Blood gas test
    • 7.1.4. Respiratory measurement devices
    • 7.1.5. Others

8. Respiratory Disease Testing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Lung cancer
    • 8.1.3. Tuberculosis
    • 8.1.4. Asthma
    • 8.1.5. Chronic obstructive pulmonary disease (COPD)
    • 8.1.6. Others

9. Respiratory Disease Testing Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinical Laboratories
    • 9.1.4. Others

10. Respiratory Disease Testing Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Respiratory Disease Testing Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Respiratory Disease Testing Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Respiratory Disease Testing Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Respiratory Disease Testing Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Respiratory Disease Testing Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Respiratory Disease Testing Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Abbott Laboratories
    • 11.2.3. F. Hoffmann-La Roche AG
    • 11.2.4. Siemens Healthineers
    • 11.2.5. Becton, Dickinson and Company (BD)
    • 11.2.6. bioMerieux SA
    • 11.2.7. Quest Diagnostics Incorporated
    • 11.2.8. Danaher Corporation
    • 11.2.9. PerkinElmer Inc.
    • 11.2.10. MGC Diagnostics Corporation
    • 11.2.11. Oxford Nanopore
    • 11.2.12. Agilent Technologies, Inc.
    • 11.2.13. Vyaire Medical, Inc.
    • 11.2.14. Philips Healthcare
    • 11.2.15. GE HealthCare Technologies In
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제